Phreesia executive sells shares worth over $17k By Investing.com

Amy Beth VanDuyn, Senior Vice President of Human Resources at Phreesia, Inc. (NYSE:), recently sold company shares totaling more than $17,000. The transaction took place on September 10, 2024, and was disclosed in a regulatory filing with the Securities and Exchange Commission.

The shares were sold at a weighted average price of $23.2502, with individual transactions occurring within a price range of $22.94 to $23.17 per share. Following the sale, VanDuyn’s holdings in Phreesia, Inc. decreased to 119,541 shares of common stock.

The transaction was part of a mandatory sell-to-cover policy implemented by Phreesia, Inc., which is intended to satisfy tax withholding obligations that arise in connection with the settlement of restricted stock units (RSUs). These types of sales are common among corporate executives and are often scheduled in advance to comply with insider trading regulations and tax obligations.

Investors and shareholders may request additional details on the exact number of shares sold at each price point within the reported range by contacting Phreesia, Inc. directly or through the SEC.

Phreesia, Inc. specializes in providing business services and is known for its innovative healthcare platform that streamlines the patient check-in process and enhances the patient experience. The company is headquartered in Wilmington, Delaware, and continues to be a key player in the business services sector.

In other recent news, Phreesia Inc . has been the subject of various analyst reviews following its latest financial results. The company reported a 19% year-over-year increase in its second-quarter revenue and a positive EBITDA of $7 million, surpassing the consensus estimate of $4 million. Financial services firm Baird raised its price target for Phreesia to $34, citing the company’s strong growth outlook.

Truist Securities also adjusted its financial outlook for Phreesia, increasing its price target to $31 due to revised expectations for the company’s financial performance in Fiscal Year 2026. Piper Sandler maintained its Overweight rating on Phreesia shares with a consistent price target of $30, expressing a positive outlook on the company’s financial performance.

Similarly, Canaccord Genuity maintained a Buy rating for Phreesia with a steady price target of $34, highlighting the company’s operational efficiency and focus on long-term profitability. Needham reaffirmed a Buy rating and a price target of $29 for Phreesia, projecting a potential double in the adjusted EBITDA margin year over year.

These recent developments indicate a positive financial trajectory for Phreesia, with multiple analyst firms expressing confidence in the company’s growth and profitability.

InvestingPro Insights

Recent market activity has shown that Phreesia, Inc. (NYSE:PHR) is navigating through challenging times. According to InvestingPro data, the company has a market capitalization of $1.37 billion and has experienced a significant price drop over the past week, with a 7.51% decline in total return. This aligns with the recent insider transaction, where Amy Beth VanDuyn, Senior Vice President of Human Resources, sold shares totaling more than $17,000.

InvestingPro Tips suggest that analysts have revised their earnings expectations upwards for Phreesia, despite the company not being profitable over the last twelve months. This optimism is reflected in a 22.1% revenue growth reported in the last twelve months as of Q2 2025, which could indicate potential for future profitability. However, analysts do not anticipate the company will be profitable this year, which is important for investors to consider when evaluating the company’s short-term prospects.

Furthermore, while Phreesia is operating with a moderate level of debt, it is trading at a high Price/Book multiple of 5.46. This could suggest that the stock is currently valued at a premium compared to its book value. Investors should note that Phreesia does not pay a dividend, thus potential returns would solely rely on stock price appreciation.

For those interested in a deeper analysis, there are additional InvestingPro Tips available on the platform, which can provide further insights into Phreesia’s financial health and market performance. Visit InvestingPro at https://www.investing.com/pro/PHR to explore these resources.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.